USA News Group CommentaryIssued on behalf of Scope AI Corp.
VANCOUVER, BC, June 13, 2024 /PRNewswire/ — The future of artificial intelligence (AI) is unfolding before our eyes. Actions made today will undoubtedly pave the way for the AI road ahead, with calls for more AI regulation, energy and grid security, and AI employee protections. All the while, investment in AI is surging, with Generative AI Venture Capital Investment on track to reach $12 billion in 2024, according to analysts at EY. Meanwhile McKinsey is predicting that generative AI alone could generate $2.6 trillion to $4.4 trillion in value across industries. This is why the market is keen on monitoring the advancements of AI developers, including Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF), Meta Platforms, Inc. (NASDAQ: META), Alphabet Inc. (NASDAQ: GOOG, GOOGL), Microsoft Corporation (NASDAQ: MSFT), and Amazon.com, Inc. (NASDAQ: AMZN).

With rapid advancements in deep machine learning, Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) has rebranded and shifted its market focus. The company is now directing its state-of-the-art GEM (General Enterprise Machine Learning) technology towards crucial sectors such as advertising, gaming, and neural networks.
Their ongoing development of GEM is working toward enabling businesses to create custom object detection and visual information systems, harnessing the full potential of neural networks. Scope AI’s strategic efforts aim to transform the fields of advertising personalization, gaming enhancements, and the various applications of neural networks.
Recently, Scope AI has unveiled significant enhancements to GEM, aimed at improving services for advertising agencies and the gaming sector. These upgrades allow GEM to refine advertising content and boost gameplay experiences with sophisticated neural network features. The improvements also strengthen the platform’s object visual recognition capabilities, enabling businesses to gain more profound insights and deploy more accurate solutions. With better object detection and visual information systems, advertisers can more effectively analyze consumer behavior and optimize their campaigns, while game developers can craft more engaging and immersive user experiences.
“We’re very pleased at how seamless we were able to streamline, enhance, and strengthen our platform with the latest performance and security upgrades made to our infrastructure,” said Sean Prescott, Founder and Non-Executive Chairman of Scope. “The next generation of our platform will set us apart in what kind of data and its sensitivity we can process and store. It’s a potential game-changer for the industry.”
Scope AI has introduced significant upgrades to their GEM platform, aiming to revolutionize the advertising and gaming industries with new advanced features and deeper insights. The intuitive web interface of GEM allows users—from developers to large enterprises—to easily implement sophisticated object detection systems and develop real-time neural network models.
In the advertising sector, GEM’s enhanced visual recognition technology facilitates the creation of highly targeted and engaging advertisements. This advancement leads to more efficient ad spending and higher customer engagement levels, transforming how ads are crafted and delivered.
For the gaming industry, Scope AI’s GEM platform is set to redefine player experiences. By analyzing player behavior through neural networks, GEM customizes gameplay and recommendations, providing developers with critical insights to improve game design, enhance player retention, and generate new revenue streams. These upgrades position GEM as a crucial tool for both industries, offering innovative solutions and driving forward technological progress.
In what seems to be a controversial move, Meta Platforms, Inc. (NASDAQ: META) is reportedly set to use social media posts from Europe to train its Llama large language models. In an interview with Reuters, Meta’s top policy executive said that the company uses public Facebook and Instagram posts to train its Llama models, while excluding private posts and messages shared only with friends.
Also noteworthy, is a CNBC report that claims an investment firm called IFiAI that uses IBM’s Watsonx to help make projections about the short-term directions of stocks, has predicted big upside in Meta Platforms in the coming month. One of the new announcements already shared this month, is the plan for Meta to introduce free AI chatbots on its popular WhatsApp messenger platform.
“They need to find a way to show investors with some degree of conviction that there is a there there,” said Mark Shmulik, an analyst for Bernstein. “An AI-powered chatbot inside of business messaging feels like a great place to deploy it. You might be able to find product market fit sooner than you will on smart glasses.”
Google parent Alphabet Inc. (NASDAQ: GOOG, GOOGL) launched a flurry of announcements in May that demonstrated the tech giant’s ambitions to beef up its AI search and chatbot options. Google’s latest innovations include the addition of Flash to its Gemini 1.5 AI model family, designed to be faster and more cost-effective. Another breakthrough is Project Astra, a prototype capable of conversing with users about anything their smartphone camera captures in real time. Additionally, Google has introduced search results organized under AI-generated headlines.
“This is a moment of growth and opportunity,” said Sundar Pichai, CEO of Alphabet, when asked if the AI updates could risk Google’s profitable business.
Additionally, Google is introducing AI Overviews to all U.S. users for its search function this week, following extensive public testing since last year’s I/O event. This feature leverages generative AI to compile information and address more complex queries that lack straightforward answers on the web.
“The AI Overviews launch reception this week will be an indicator of how well Google can adapt its Search product to meet the demands of the generative AI era,” said Jacob Bourne, analyst of eMarketer. “To maintain its competitive edge and satisfy investors, Google will need to focus on translating its AI innovations into profitable products and services at scale.”
After an outcry regarding privacy concerns, Microsoft Corporation (NASDAQ: MSFT) recently backtracked on a plan to have its new AI-powered PCs utilize a “Recall” feature that would capture and store screenshots of users’ desktop activities. Moving on from the controversy, it appears Microsoft is now considering a big new software bundle plan to monetize AI features in its popular productivity software suite Microsoft 365, according to sources as reported by Business Insider.
Meanwhile, the market is paying close attention to an ongoing investigation by the Federal Trade Commission (FTC) regarding a deal with AI startup Inflection. The FTC is investigating whether Microsoft’s investment in Inflection should have been classified as an acquisition that the company failed to disclose to the government, according to a source reported by CNN.
“Our agreements with Inflection gave us the opportunity to recruit individuals at Inflection AI and build a team capable of accelerating Microsoft Copilot, while enabling Inflection to continue pursuing its independent business and ambition as an AI studio,” said a Microsoft spokesperson in a statement to CNN, adding that the company is “confident” it has complied with its reporting obligations.
For eCommerce and data center giant Amazon.com, Inc. (NASDAQ: AMZN), its subsidiary Amazon CloudWatch recently announced the general availability of natural language query generation powered by generative AI for Logs Insights and Metrics Insights. This feature allows users to effortlessly create queries within the context of their logs and metrics data using plain language. By streamlining the query generation process, it enables the user to quickly derive insights from observability data without requiring deep knowledge of the query language.
Amazon’s subsidiary Amazon Web Services (AWS) also recently debuted 2 new AI certifications to train more people and give them an edge in the pursuit of the growing number of in-demand cloud jobs. The AWS certifications include the AWS Certified AI Practitioner foundation-level certification, and the AWS Certified Machine Learning Engineer – Associate certification for individuals with at least a year of experience building, deploying, and maintaining AI and ML solutions on AWS. To date, AWS provides over 100 courses and learning resources in AI, ML, and generative AI through AWS Skill Builder and AWS Educate, equipping learners for the future of work.
Article Source: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/ 
CONTACT:
USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Scope AI Corp. advertising and digital media from the company directly. There may be 3rd parties who may have shares Scope AI Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Scope AI Corp. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Scope AI Corp. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/ai-development-accelerates-market-watch-on-emerging-ai-innovations-302172161.html

STOCKHOLM, June 13, 2024 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces the election of Jesper Høiland as the new Chairman of the Board.

We are pleased to announce the election of Jesper Høiland as the new Chairman of the Board. Jesper has over 25 years of experience from senior positions in global pharmaceutical companies such as Ascendis Pharma (CCO), Radius Health (CEO) and Novo Nordisk (President and EVP for the US with a particular focus on pricing, product launches and infrastructure building). Jesper has lived and worked in the US, Switzerland, Denmark, Australia, France, Belgium and Canada for the past 30 years. 
“We are happy about the election of Jesper Høiland as the new Chairman of our board,” says Pia Renaudin CEO of SciBase. “He will bring valuable insights and experience especially from the US market, which is our primary focus. We also welcome, as previously communicated, Robert Molander as new member of the Board.”
In addition, we would like to extend our gratitude to Tord Lendau for his commitment and invaluable contributions during his lead as Chairman of the Board. Tord has been a member of the board since 2014. During this time SciBase has made significant progress in navigating challenging regulatory processes and market environments and has reached profitability in Germany through growing sales of Nevisense and electrodes. Nevisense remains the only melanoma detection product approved in the US. The foundation for further growth has been laid.
“We extend our deepest thanks to Tord for his exceptional leadership and commitment to SciBase,” says Pia Renaudin. “He has been instrumental in SciBase progress. I also want to take the opportunity to thank both Dr Matt Leavitt and Jvalini Dwarkasing for their support in driving SciBase forward as they now retire as members of the Board.”
SciBase is excited about the future and remains committed to become the standard of Care in the areas we work in. We look forward to achieving new milestones and providing our AI driven technology to clinicians so they can improve and save lives through timely detection and intervention at the first signs of skin diseases and to reduce healthcare costs.
For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected] Advisor (CA):Vator SecuritiesTel: +46 8 580 065 99Email: [email protected]
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press releases and financial reports can be found here: http://investors.scibase.se/en/pressreleases 
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/scibase/r/scibase-welcomes-new-chairman-and-thanks-the-former,c4000649
The following files are available for download:
https://mb.cision.com/Main/12371/4000649/2864256.pdf
PM_new CoB final
 

View original content:https://www.prnewswire.co.uk/news-releases/scibase-welcomes-new-chairman-and-thanks-the-former-302172126.html

NEWBURY, England, June 13, 2024 /PRNewswire/ — Osteotec, the market-leading manufacturer and distributor of medical devices, is proud to announce a new partnership with Additive Surgical, the innovative Adelaide-based company renowned for its pioneering 3D-printed spinal implant technologies.

This collaboration marks a significant milestone in Osteotec’s expansion into the spine sector, promising to deliver unparalleled support and advanced solutions to UK orthopaedic and neurosurgeons.
Established in 2020, Additive Surgical is the first company in Australia to offer off-the-shelf 3D-printed titanium spinal implants. After years of research and development the portfolio features proprietary PorOssity™ technology, featuring intricate biomimetic lattices and targeted porosity that promote bone growth—capabilities previously unattainable through traditional manufacturing methods.
“This partnership is a testament to our dedication to bringing cutting-edge technologies to the UK market,” said Osteotec National Spine Sales Manager Lisa Watts. “By working with Additive Surgical we can offer surgeons innovative, customisable products that improve patient outcomes. We are excited to integrate Additive Surgical’s differentiated 3D-printed implants into our product line-up and offer UK surgeons unparalleled solutions for their patients.”
Additive Surgical’s unique approach empowers surgeons with significant design input, facilitating rapid iteration and customisation of implant designs. It’s the clinicians themselves that truly understand what the unmet clinical needs are in spinal surgery, and how to design a spine implant to solve these needs.
This clinician-led innovation model has garnered partnerships with leading orthopaedic and neurosurgeons across Australia and New Zealand, positioning Additive Surgical at the forefront of the medtech industry. Additive Surgical have developed advanced capability in biomimetic lattice structures and agile manufacturing processes that allows them to significantly shorten the iterative-design-feedback loop. This in turn enables their unique approach to medical device development and manufacturing.
The partnership with Additive Surgical will see Osteotec exclusively distribute their novel spinal implant technologies across the UK.
Gibran Maher, CEO and Co-Founder of Additive Surgical, said: “Our collaboration with Osteotec is an exciting step forward in our mission to bring cutting-edge spinal implant technology to the global market. Osteotec’s longstanding reputation and deep connections within the UK medical community make them an ideal partner to introduce our innovative 3D-printed solutions to UK surgeons. We can’t wait to officially launch in the UK market in the spring of 2025.”
Both companies are excited to begin engaging with leading UK surgeons over the coming months to understand specific clinical challenges and develop tailored solutions. This collaboration not only underscores Osteotec’s continued growth and innovation but also reaffirms its position as a leader in the orthopaedic and spine medical device industry.
About Osteotec 
Osteotec is a manufacturer and distributor of medical devices headquartered in Newbury, UK, with offices in Dublin and Malmö. Established in 1993, Osteotec has been supplying into the NHS and private healthcare sectors for the past 31 years.
Osteotec manufactures the Osteotec Silicone Finger, ChiroKlip and the Concentric Bone Graft System and is a distribution partner of choice for world-leading orthopaedic and spine partners including TriMed, SI-BONE, Enovis and Mathys.
Media Contact:
Ric SumnerHead of [email protected] | 020 3011 5574 For more information, visit – https://osteotec.com/ www.osteotec.com
About Additive Surgical
Additive Surgical was established in 2020 and is the first company in Australia to manufacture off-the-shelf 3D printed titanium spinal implant technologies, using state of the art, European IP. The entire Additive Surgical team is dedicated and passionate about manufacturing the highest quality medical technology in Australia that positively impact the lives of people globally.
Media Contact:Gibran MaherCEO and [email protected] | +61410404755For more information, visit www.additive-surgical.com 
Logo – https://mma.prnewswire.com/media/2151731/4760763/Osteotec_Logo.jpg
 
 

View original content:https://www.prnewswire.co.uk/news-releases/osteotec-announces-strategic-collaboration-with-additive-surgical-bringing-cutting-edge-3d-printed-spine-technology-to-the-uk-302172053.html